EPISODE · Jan 22, 2026 · 3 MIN
Ilika CEO hails first purchase order for Stereax electrodes from Cirtec Medical
from Proactive - Interviews for investors · host Proactive Investors
Ilika PLC (AIM:IKA, OTCQX:ILIKF) CEO Graeme Purdy joined Stephen Gunnion in the Proactive studio with more on the company’s transition into revenue generation through its partnership with Cirtec Medical and the commercial rollout of its Stereax solid-state battery technology. Purdy discussed what he described as a significant milestone for the company, as it moves from a technology transfer phase into product shipments and early revenues through Cirtec Medical. He explained that an initial purchase order from Cirtec marks the point where Ilika is “now starting to ship products to customers,” following the successful transfer of Ilika’s process technology and product know-how to Cirtec. He noted that Ilika is supplying electrodes from its UK facility to support Cirtec’s manufacturing activities, describing this as “an early indicator that revenues are starting to ramp.” Purdy also outlined why Ilika has retained cathode deposition and battery formation in the UK, explaining that this is the most proprietary part of the Stereax manufacturing process and requires significant expertise to achieve high yields. Retaining this step, he said, allows Ilika to generate early revenue while maintaining control over a critical part of the value chain. Looking ahead, Purdy highlighted key milestones investors should watch over the next 6 to 12 months, including integration of the Stereax battery into Cirtec technology platforms, entry into customer devices, and the start of regulatory approval processes. He added that industry events such as the North American Neuromodulation Society meeting and MD&M West play an important role in driving customer engagement and business development. Purdy summed up the progress by saying the developments signal an exciting period ahead as Ilika works towards scaling revenues. For more interviews like this, visit Proactive’s YouTube channel, give the video a like, subscribe to the channel, and turn on notifications so you never miss an update. #Ilika #IlikaPLC #GraemePurdy #Stereax #SolidStateBatteries #CirtecMedical #BatteryTechnology #MedicalDevices #RevenueGrowth #UKStocks #SmallCapStocks #InvestorNews #ProactiveInvestors
What this episode covers
Ilika PLC (AIM:IKA, OTCQX:ILIKF) CEO Graeme Purdy joined Stephen Gunnion in the Proactive studio with more on the company’s transition into revenue generation through its partnership with Cirtec Medical and the commercial rollout of its Stereax solid-state battery technology. Purdy discussed what he described as a significant milestone for the company, as it moves from a technology transfer phase into product shipments and early revenues through Cirtec Medical. He explained that an initial purchase order from Cirtec marks the point where Ilika is “now starting to ship products to customers,” following the successful transfer of Ilika’s process technology and product know-how to Cirtec. He noted that Ilika is supplying electrodes from its UK facility to support Cirtec’s manufacturing activities, describing this as “an early indicator that revenues are starting to ramp.” Purdy also outlined why Ilika has retained cathode deposition and battery formation in the UK, explaining that this is the most proprietary part of the Stereax manufacturing process and requires significant expertise to achieve high yields. Retaining this step, he said, allows Ilika to generate early revenue while maintaining control over a critical part of the value chain. Looking ahead, Purdy highlighted key milestones investors should watch over the next 6 to 12 months, including integration of the Stereax battery into Cirtec technology platforms, entry into customer devices, and the start of regulatory approval processes. He added that industry events such as the North American Neuromodulation Society meeting and MD&M West play an important role in driving customer engagement and business development. Purdy summed up the progress by saying the developments signal an exciting period ahead as Ilika works towards scaling revenues. For more interviews like this, visit Proactive’s YouTube channel, give the video a like, subscribe to the channel, and turn on notifications so you never miss an update. #Ilika #IlikaPLC #GraemePurdy #Stereax #SolidStateBatteries #CirtecMedical #BatteryTechnology #MedicalDevices #RevenueGrowth #UKStocks #SmallCapStocks #InvestorNews #ProactiveInvestors
NOW PLAYING
Ilika CEO hails first purchase order for Stereax electrodes from Cirtec Medical
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.